Mestag Therapeutics to present targeted LTBR agonist MST-0312 at AACR Annual Meeting

Senhwa Biosciences secures up to TWD500m funding for AI-driven drug development

CrossBridge Bio to be acquired by Eli Lilly

IDEAYA Biosciences and Servier report positive results from Phase 2/3 trial of darovasertib/crizotinib combination

Kazia Therapeutics in-licenses SETDB1 inhibitor drug development platform

Kelun-Biotech reports Phase II study results for sac-TMT at 2026 SGO

Genmab reports positive safety data for Rina-S combination in ovarian cancer

GSK reports strong early-stage data for B7-H4 ADC in gynaecological cancers

FDA grants priority review to ifinatamab deruxtecan in small cell lung cancer

Qlucore launches AI-based AML test

AnBogen Therapeutics to present Imofinostat (ABT-301) breakthroughs at AACR 2026

Verastem Oncology presents two-year follow-up data on avutometinib and defactinib in recurrent low-grade serous ovarian cancer

DualityBio reports China NMPA acceptance of BLA for T-Pam for treatment of unresectable or metastatic HER2-positive breast cancer

Oricell Therapeutics completes USD110m pre-IPO financing

Tempus expands oncology collaboration with Gilead to accelerate AI-driven R&D